NCT07297836 Professional Practices Regarding Treatment of Non-vital Primary Teeth Among Dental Surgeons in France
| NCT ID | NCT07297836 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Strasbourg, France |
| Condition | Pulpitis - Irreversible |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-11-07 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-11-07 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
When faced with primary teeth affected by irreversible pulpitis or pulp necrosis, extraction is often the preferred option for practitioners, although validated alternatives exist, notably pulpectomy, which has high success rates when performed correctly. Recommended by the American Academy of Pediatric Dentistry, this technique relies on rigorous disinfection and the use of materials adapted to natural exfoliation. Lesion sterilization tissue repair (LSTR), although more controversial due to the use of topical antibiotics, can also be considered in certain clinical situations. However, data on French practices in this area are very limited, hence the need to evaluate practitioners' treatment choices, their potential reservations, and the criteria guiding their decisions.
Eligibility Criteria
Inclusion Criteria: * Being a dentist treating children Exclusion Criteria: * Being a dentist treating children
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07297836 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pulpitis - Irreversible. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07297836 currently recruiting?
Yes, NCT07297836 is actively recruiting participants. Contact the research team at françois.clauss@chru-strasbourg.fr for enrollment information.
Where is the NCT07297836 trial being conducted?
This trial is being conducted at Strasbourg, France.
Who is sponsoring the NCT07297836 clinical trial?
NCT07297836 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 100 participants.